跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TachoSil - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
TachoSil
Approved
STANDARD
TachoSil
TAKEDA AUSTRIA GMBH
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
1ab51de3489437d3
Company
TAKEDA AUSTRIA GMBH
Type
Standard
Approval Details
Approval Id
1ab51de3489437d3
Drug Approval Philippines Name
TachoSil
Product Name
TachoSil
Registration Number
BR-1393
Brand Name
TachoSil
Generic Name
Human Fibrinogen + Human Thrombin
Dosage Form
Medicated Sponge
Dosage Strength
5.5 mg/2.0 IU per cm2
Manufacturer
TAKEDA AUSTRIA GMBH
Importer
PE Pharma ENTERPRISES OPC
Distributor
PE Pharma ENTERPRISES OPC
Company Detail Path
/organization/takeda-austria-gmbh
Issuance Date
07 April 2024
Expiry Date
04 March 2029
Pharmacologic Category
Local Hemostatic Agents
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
1ab51de3489437d3
Type
Standard
Back to Philippines FDA Approvals